CompletedNot Applicable

Fetal Renal Artery Doppler in Patients With Preeclampsia

Egypt114 participantsStarted 2024-11-01

Plain-language summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * a) Preeclampsia: * Women with preeclampsia \>28 weeks of pregnancy. * Singleton pregnancy. * Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data. b) Control: * Women with healthy pregnancy matched by closest gestational age. Exclusion Criteria: * ● Multiple pregnancy. * Known Congenital fetal malformations. * Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders. * Women unable to provide informed consent. * Women who refuse to participate

What they're measuring

fetal renal artery doppler indices

Timeframe: 1 year

Middle cerberal artery doppler indices , Umbilical artery doppler indices and placental volume

Timeframe: 1 year

Trial details

NCT IDNCT06395974

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Preeclampsia trials